Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Children's cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Closed
Phase 2
This trial is looking at nilotinib for children and young people who have Philadelphia positive chronic myeloid leukaemia.
Recruitment start: 21 May 2014
Recruitment end: 31 May 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pamela Kearns
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 30 May 2015
CRUK internal database number: 11203